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Abstract 
Intestinal permeability, characterized as leaky-gut syndrome, is a debilitating 
gastrointestinal disorder that leads to inflammation and altered immune response. Tight 
junctions are crucial for cell-to-cell adhesion and regulation of paracellular transport of 
molecules across the intestinal epithelium. However, the exact mechanism of the leaky-
gut state encountered in autistic spectrum disorders is not known. Mercury, both as 
inorganic and organic forms, has been identified as a serious environmental pollutant, 
occupational hazard, and pharmaceutical toxicant. Mercury, in the form of thimerosal in 
vaccines, has been implicated as one of the causative species of autism. Therefore, here, 
we hypothesized that mercury would cause intestinal epithelial cell tight junction 
alterations and paracellular hyperpermeability (leak) through oxidative stress and thiol-
redox dysregulation which could lead to the leaky-gut condition. Hence, we investigated 
the mechanism of tight junction alteration and paracellular leak of macromolecules in the 
well-established in vitro intestinal (colon) epithelial Caco-2 cell model. We also 
identified efficacy of the thiol-redox stabilization drugs to protect against the mercury-
induced damage in the Caco-2 cells in vitro. Our studies revealed that the two forms of 
mercury, methylmercury and thimerosal caused (i) dose- and time-dependent cytotoxicity 
(lactate dehydrogenase release, decreased mitochondrial integrity, and cell morphological 
alterations), (ii) loss of intracellular glutathione (GSH), (iii) increase in the formation of 
reactive oxygen species, (iv) loss of barrier dysfunction; (v) loss of cell proliferation, (vi) 
actin cytoskeletal rearrangement (actin stress fiber formation), (vii) tight-junction (ZO-1 
protein and occludins) alterations, and (viii) increase in paracellular leak of 
macromolecules in Caco-2 cells in vitro.  Mercury-induced cytotoxicity, tight junction 
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alterations, and increase in paracellular leak were significantly attenuated by the novel 
lipophilic thiol-redox-stabilizing antioxidant and heavy metal chelator, N,N’-bis-(2-
mercaptoethyl)isophthalamide (NBMI). For the first time, the results of the current study 
demonstrated that mercury (methylmercury and thimerosal) caused intestinal epithelial 
cell damage and macromolecule leak through thiol-redox dysregulation and oxidative 
stress which was effectively protected by the novel lipophilic thiol-redox stabilizer and 
heavy metal chelator, NBMI. Our findings emphasize the significance of altered cellular 
functioning by the intestinal epithelium upon exposure to mercuric agents, and 
pharmacological attenuation by the novel drug, NBMI.  
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Introduction 
Mercury is a prevalent environmental toxin that poses significant health concerns 
to humans and the environment. Mercury enters the environment and life forms including 
humans as inorganic form (metallic mercury vapor), organic mercury form (e.g. 
methylmercury), and pharmaceutical form (e.g. thimerosal). Sources of human exposure 
to mercury vary widely but include consumption of contaminated fish, exposure to power 
plant emissions, inoculation with vaccines preserved with the mercury containing 
thimerosal, and leeching from dental amalgams. Occupational and environmental 
exposure to mercury and other toxic metals including chromium, cadmium, and lead 
increase one’s risk of heavy metal poisoning. Ingestion and inhalation of mercury and 
other heavy metals can result in many chronic and/or acute physiologic conditions. 
Specifically, mercury poisoning can result in upper respiratory tract diseases, lung 
diseases, cardiovascular disease, musculoskeletal disorders, and nervous system diseases 
including neurodegeneration.  
 The biomethylation of inorganic mercury by microorganisms leads to the 
formation of methylmercury, an organic and more toxic form of mercury (Dopp et al. 
2011). Exposure to the organic form of mercury poses a greater risk to human health. 
Humans’ consumption of contaminated fish is a primary mode of exposure to 
methylmercury. Many industrial processes result in contamination of marine 
environments, allowing aquatic bacteria to convert less hazardous inorganic mercury to 
the more toxic organic form. Consequently, both freshwater and saltwater fish have 
shown to be contaminated with methylmercury. When consumed by humans, mercury-
contaminated fish are a source of mercury poisoning and a causative agent in human 
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disease. Therefore, exposure to methylmercury is a significant public health concern that 
warrants further investigation including examination of the cellular mechanism(s) of 
toxicity which are poorly understood.  
In addition to the aforementioned adverse health effects, mercury has been 
implicated as a contributor to leaky-gut syndrome, or intestinal hyperpermeability. 
Leaky-gut syndrome is a condition in which alterations within the gastrointestinal 
epithelium compromise the guts selectively permeable luminal membrane. Specifically, 
disruptions in the essential intercellular tight junctions, which are mediated by ZO-1 and 
occludin proteins, facilitate dysregulated migration of bacteria, nutrients, and 
macromolecules. Such disruptions of intestinal barrier function and lack of epithelial 
junction integrity has been implicated as a causative agent of autoimmune and 
inflammatory diseases (Groschwitz & Hogan et al. 2009). However, the mechanisms by 
which mercury may contribute to process in not know.   
 Earlier, we reported that mercury induced toxicity in endothelial cells through 
generation of ROS and thiol-redox destabilization (Secor, et al.). However, the complete 
cellular mechanisms of mercury toxicity remain unclear and the effects on the 
gastrointestinal tract, specifically colonic epithelium, remain uninvestigated. The colonic 
epithelium is a monolayer lining the interior of the small and large intestines and is 
important for gastrointestinal function and health. The intestinal epithelium forms a 
barrier that separates the gastrointestinal lumen from the basolateral membrane and 
underlying capillary bed. Additionally, the intestinal epithelium is an integral regulator of 
digestion and facilitator of absorption which regulates transmigration. The structural 
integrity of this membrane is conferred in large part by the tight junctions between 
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intestinal epithelial cells. Tight junctions, while preventing invasion by enteric bacteria, 
do not form impermeable seals but allow paracellular absorption of essential nutrients. 
The functional importance of a dynamic, selectively permeable layer of cells (e.g. 
epithelial cells of the intestine) is mediated by the architecture of cytoskeleton proteins 
which compose tight junctions. Studies have shown that the tight junction barrier is 
highly-regulated and is modulated by actin cytoskeletal arrangement (Shen & Turner et 
al. 2006). Disruption of the intestinal epithelium through alteration of the actin 
cytoskeleton results in the intestinal hyperpermeability disorders and leaky-gut syndrome. 
 Consequently, here we hypothesized that mercury exposure compromises the 
structural integrity of the intestinal epithelium by causing cytotoxicity in intestinal 
epithelial cells through generation of ROS, disruption of tight junctions, and induction of 
cytoskeletal rearrangements which contribute to leaky-gut syndrome. Moreover, the 
leaky-gut syndrome is also encountered among autistic spectrum disorders. Therefore, 
here we tested our hypothesis by using our established intestinal Caco-2 colon epithelial 
cell model to investigate the cytotoxicity of mercury (as methylmercury and thimerosal). 
We assayed cytotoxicity using lactate dehydrogenase (LDH) release, MTT reduction 
(mitochondrial function), and cellular proliferation. We also measured changes due to 
mercury in intracellular glutathione (GSH) and ROS. Lastly, we indexed the effects of 
mercury on membrane integrity through determining trans-epithelial electrical resistance 
(TEpR) and macromolecule (FITC-dextran) leak across the paracellular gaps. For the first 
time, this study demonstrated a time- and dose-dependent cytotoxic effect of mercury on 
the colon epithelial cells. Furthermore, we demonstrated that mercury acted through 
depleting intracellular thiols (glutathione, GSH) and generation ROS which led to 
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cytoskeletal rearrangements and membrane dysfunction and, ultimately, cytotoxicity and 
paracellular hyperpermeability. Lastly, we report that the novel lipophilic thiol-redox 
stabilizing antioxidant and heavy metal chelator, N,N’-bis-(2-
mercaptoethyl)isophthalamide (NBMI), attenuated the mercury-induced cytotoxicity, 
cytoskeletal rearrangement, tight junction alterations, and paracellular hyperpermeability 
by inhibiting the generation of ROS and preventing loss of intracellular thiols. 
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MATERIALS AND METHODS 
 
Materials 
Caco-2 cells used in this study, 1X trypsin-EDTA solution, Penicillin-
Streptomycin solution, and Eagle’s Minimum Essential Medium (EMEM) were obtained 
from ATCC (Manassas, VA). Phosphate-buffered saline (PBS) was obtained from 
Biofluids Inc. (Rockville, MD). Minimal essential medium (MEM), nonessential amino 
acids, fetal bovine serum (FBS), tissue culture reagents, meso-2,3-dimercaptosuccinic 
acid (DMSA), N-acetyl-L-cysteine (NAC), 3-[4,5-Dimethylthiazol-2-yl]-2, 5-diphenyl 
tetrazolium bromide reduction kit (MTT assay kit), lactate dehydrogenase cytotoxicity 
assay kit (LDH release assay kit), t-octylphenoxypolyethoxyethanol (Triton X-100), 
bovine serum albumin (BSA),  and analytical reagents of highest purity were all 
purchased from Sigma Chemical Co. (St. Louis, MO). PD98059 was obtained from 
Calbiochem (San Diego, CA). Anti-rabbit AlexaFluor 488-conjugated antibody was 
purchased from Molecular Probes Invitrogen Co. (Carlsbad, CA). GSH 
chemiluminescence assay kit (GSH-Glo) was obtained from Promega Corporation 
(Madison, WI). [3H]-Thymidine was obtained from American Radiolabeled Chemicals, 
Inc. (St. Louis, MO). ECIS electrode arrays were obtained from Applied Biophysics 
(Troy, NY). Paraformaldehyde was purchased from Electron Microscopy Sciences (Fort 
Washington, PA). Mouse anti-ZO1, anti-occludin antibody was obtained from Zymed 
Laboratories (San Francisco, CA). Polyoxyethylene sorbitan monolaurate (Tween-20) 
was purchased from Bio-Rad Laboratories (Hercules, CA).  
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NBMI Synthesis 
NBMI was synthesized using a modification of the method of Matlocket al. 
(2003) at the University of Kentucky by Gupta under the supervision of Haley. Three 
grams of 2-aminoethylthiol hydrochloride was dissolved in 25 ml of chloroform and 3.7 
ml of triethylamine and placed in an ice bath with stirring. A total of 2.68 g of 
isophthaloyl chloride was dissolved in 25 ml of chloroform and slowly added to the 
solution containing 2-aminoethylthiol and allowed to stir for 2 h on ice. A precipitation of 
the NBMI was induced by adding about 100 ml of 0.1 N HCl slowly to the stirring 
mixture. The resulting precipitate was collected by filtration and washed two times with a 
water:chloroform (50/50) mixture and then two times with 0.1 N HCl and three times  
with distilled water. The resulting white powder was dried under vacuum and yielded the 
product NBMI in 70% yield. Gram amounts of this powder were dissolved in pure 
ethanol and recrystallized twice resulting in the final product. NBMI purity was 
determined by LC-MS/MS. Column was a Waters X-Bridge C-18 (150 × 3.0 mm, 5 µm 
particle size). The mobile phase consisted of (A) aqueous with 0.1% formic acid and (B) 
methanol with 0.1% formic acid. A gradient system was used, and the total run time was 
30 min. The elution conditions expressed as % of B is as follows: 0–30 s 10% B, 30 s–10 
min 10–90% B, 10–19 min 90% B, 19–20 min 90–10% B, and 20–30 min 10% B. 
Injection volume was 10 µl. Flow rate was 250 µl/min and the retention time for NBMI 
was 9.81 min. Analysis was done on a Varian LC 1200 L Triple Quadruple MS, using a 
positive electro-spray ionization source.  
 
Cell Culture 
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Caco-2 cells were cultured in EMEM supplemented with 20% (vol/vol) fetal 
bovine serum, 100 units/ml penicillin and streptomycin, and 1% (vol/vol) non-essential 
amino acids at 37oC under a humidified 95% air - 5% CO2 atmosphere. Cells in culture 
were maintained at 37ºC in a humidified environment of 95% air - 5% CO2 and grown to 
contact-inhibited monolayers with typical cobblestone morphology.  When confluence 
was reached, cells were trypsinized and subcultured in T 75-cm2 flasks or 35 X 10-mm or 
100-mm tissue culture dishes.  Confluent cells showed cobblestone morphology under 
light microscope.  All experiments were conducted between 8 and 30 passages (80-90% 
confluence). All media and treatments were carefully adjusted to pH 7.4 before use. 
 
Lactate Dehydrogenase (LDH) Release Assay for Cytotoxicity 
Cytotoxicity in Caco-2 cells was determined by assaying the extent of release of 
LDH from cells according to our previously published method (Patel et al., 2011). At the 
end of treatment, the medium was collected and LDH released into the medium was 
determined spectrophotometrically by using the commercial LDH assay kit according to 
the manufacturer’s recommendations (Sigma Chemical Co., St. Louis, MO). 
 
MTT Reduction Assay for Cytotoxicity 
Cytotoxicity in Caco-2 cells was determined by assaying the extent of reduction 
of MTT in intact cells by using the commercial MTT reduction assay kit as previously 
shown (Sliman et al., 2009).  At the end of the experimental treatments, MTT solution 
(10% by vol in MEM) was added and the cells were incubated for 3 h, following which 
MTT solvent was added in an amount equal to the original culture volume. Absorbance 
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of the reduced MTT was determined spectrophotometrically according to the 
manufacturer’s recommendations (Sigma Chemical Co., St. Louis, MO).  
 
Morphology Assay of Cytotoxicity 
Morphological alterations in Caco-2 cells cultured in 35-mm dishes up to 70% 
confluence, following their exposure to mercury and other pharmacological treatments 
for 1 and 2 h, were examined as an index of cytotoxicity according to our previously 
established method (Mazerik et al. 2007). Images of cell morphology were digitally 
captured with the Olympus microscope at 20x magnification. 
 
[3H]-Thymidine incorporation assay for cell proliferation 
Caco-2 cells were grown to 60% confluence in 35-mm dishes. Complete medium 
was removed from the culture dishes and the treatment solutions were added to the 
dishes. The treatment medium was then removed and 1 ml of [3H]-thymidine (1 µCi/ml) 
in MEM was added to each well and incubated for 24 h. After incubations, [3H]-
thymidine was removed and cells were washed twice with ice-cold PBS. Cells were then 
washed twice with 5% trichloroacetic acid (TCA) in distilled water. Washings of 5% 
TCA were then removed and the cells were treated with 10.25 M NaOH (500 µL) for 30 
min to solubilize the cells. The solubilized cell solution (400 µL) was transferred to the 
scintillation vials followed by the addition of 10 mL of scintillation cocktail, and then the 
[3H] radioactivity was counted in the Packard Tri-carb 2900TR liquid scintillation 
counter. 
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Measurement of Transepithelial Cell Electrical Resistance 
The transepithelial cell electrical resistance (TEpR) was measured according to 
our previously published method (Sliman et al. 2010). Caco-2 cells were cultured up to 
90% confluence in complete MEM on gold electrodes (Applied Biophysics Inc., Troy, 
NY) under a humidified atmosphere of 95% air - 5% CO2 at 37°C. The EC monolayers 
were then treated with MEM alone or MEM containing the desired concentrations of the 
pharmacological agents for 2 h. TEPCR of the monolayers was continuously measured 
on ECIS (Applied Biophysics Inc., Troy, NY) following the treatment of cells with MEM 
containing methylmercury (10 µM) or thimerosal (25 µM) under a humidified 
atmosphere of 95% air - 5% CO2 at 37°C. 
 
GSH Determination 
Intracellular soluble thiol (GSH) levels were determined using the GSH-Glo GSH 
assay kit as reported earlier (Patel et al., 2011).  Caco-2 cells grown up to 90% 
confluence in 96 well plates were treated with MEM alone or MEM containing desired 
concentrations of treatments under a humidified 95% air - 5% CO2 atmosphere. 
Following incubation, intracellular GSH levels were determined according to the 
manufacturer’s recommendations (Promega Corp. Madison, WI). 
 
Measurement of Paracellular Epithelial Permeability 
Caco-2 cells were grown to 80% confluence in 12-well Corning 3.0 µm pore-size 
culture inserts (Lowell, MA). The epithelial cell monolayers were treated with MEM 
alone or MEM containing selected pharmacological agents and methylmercury (10 µM) 
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or thimerosal (25 µM) for 2 h under a humidified atmosphere of 95% air - 5% CO2 at 
37°C. Following treatments, FITC-dextran (30 kDa) dissolved in phenol-free MEM was 
placed on the apical side of the monolayer, in the insert, and the cells were then incubated 
for 1 h under a humidified atmosphere of 95% air - 5% CO2 at 37°C. The fluorescence of 
the FITC-dextran that leaked through the paracellular gaps of the EC monolayer was 
measured on a Bio-Tex ELx808 fluorescent plate reader set at 480 nm excitation and 540 
nm emission, using appropriate blanks. The extent of FITC-dextran found in the basal 
side of the EC monolayer was expressed as arbitrary fluorescence units. 
 
Reactive Oxygen Species Measurement by 2’-7’-Dichlorofluorescin Diacetate 
Fluorescence 
Formation of ROS in Caco-2 cells in 35-mm dishes (5x105cells/dish) was 
determined by 20-70-dichlorofluorescin diacetate (DCFDA) fluorescence in cells 
preloaded with 10mmol/L DCFDA for 30 min in complete MEM at 37C in a 95% air and 
5% CO2 environment prior to experimental treatments, according to our previously 
published procedure. 2’-7’-Dichlorofluorescin diacetate fluorescence as an index of 
intracellular ROS generation was visualized under Olympus fluorescence microscope at 
50X magnification with excitation and emission set at 490 and 530 nm, respectively. 
Intracellular ROS formation was quantified by measuring DCFDA fluorescence in lysates 
of cells on a Bio-Tex ELx808 fluorescent plate reader set at 490 nm excitation and 530 
nm emission, using appropriate blanks. The extent of intracellular ROS formation was 
expressed as the arbitrary fluorescence units. 
 
 18
Fluorescence microscopy of actin stress fibers 
Formation of actin stress fibers, as an index of epithelial cytoskeletal 
reorganization, was examined by fluorescence microscopy according to our previously 
published method (Sliman et al., 2010). Caco-2 cells cultured on sterile coverslips 
(Harvard Apparatus, 22 mm2) in 35-mm sterile dishes at a density of 104 cells/dish were 
treated with MEM alone, MEM containing desired concentrations of mercury, or MEM 
containing selected pharmacological agents and desired concentrations of mercury for 30 
min under a humidified atmosphere of 95% air - 5% CO2 at 37°C. At the end of the 
incubation period, cells cultured on coverslips were washed with 1x PBS, fixed with 
3.7% of paraformaldehyde for 10 min, permeabilized with 0.25% Triton X-100 in TBST 
containing 0.01% Tween-20 for 5 min, and blocked for 30 min with 1% BSA in 0.01% 
TBST. Actin stress fibers were visualized by staining the cells with rhodamine-phalloidin 
(1:50 dilution) in 1% BSA in TBST for 1 h. The cells were then washed four times with 
PBS, stained with 1% DAPI in PBS for 5 min, washed four times with PBS, mounted, 
and examined under Zeiss LSM 510 Confocal/Multiphoton Microscope at 543 nm 
excitation and 565 nm emission under 63x magnification. The images were captured 
digitally. The extent of the fluorescence intensity was measured using the Scion Image 
software. 
 
Immunofluorescence microscopy of tight junction proteins 
Caco-2 cells cultured on sterile coverslips (Harvard Apparatus, 22 mm2) in 35-
mm sterile dishes at a density of 104 cells/dish were treated with MEM alone or MEM 
containing desired concentrations of mercury or MEM containing selected 
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pharmacological agents and desired concentrations of mercury  for 30 min under a 
humidified atmosphere of 95% air - 5% CO2 at 37°C. At the end of the incubation period, 
cells cultured on coverslips were washed with PBS, fixed with 3.7% of paraformaldehyde 
for 10 min, permeabilized with 0.25% Triton X-100 in Tris-buffered saline Tween-20 
(TBST) containing 0.01% Tween-20 for 5 min, blocked for 30 min with 1% BSA in 
0.01% TBST, and then incubated for 12 h at room temperature with mouse primary anti-
occludin and anti-ZO-1 antibodies at a dilution of 1:200 (vol/vol) for the visualization of 
tight junction protein localized on the cellular membrane. Following the treatment of 
cells with the primary antibody, the cells were incubated with secondary anti-mouse 
AlexaFluor 488-conjugated antibody (1:100 dilution, vol/vol) for 1 h at room 
temperature. The coverslips with cells were then mounted on a glass slide with the 
antifade mounting medium, Fluoromount-G, and viewed with Ziess Confocal microscope 
at 63x magnification. The pictures were captured digitally, and the fluorescence intensity 
was quantified using the Scion Image software. 
 
Statistical Analysis 
All experiments were done in triplicate. Data were expressed as mean ± standard 
deviation (SD). Statistical analysis was carried out by ANOVA using SigmaStat (Jandel). 
The level of statistical significance was taken as P < 0.05.
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RESULTS 
Mercury induces cytotoxicity in colonic epithelial cells 
In earlier studies, we reported that mercury induced cytotoxicity in bovine 
pulmonary artery endothelial cells (BPAECs) (REF). However, the effect of mercury 
treatment on Caco-2 cells is not known. With this data in consideration and as the first 
step in testing our hypothesis, we set out to determine whether mercury (as 
methylmercury or thimerosal) would cause cytotoxicity in our Caco-2 model. To 
determine this possibility, Caco-2 cells were treated with methylmercury (1, 5, and 10 
µM) and thimerosal (5, 10, and 25 µM) for 1 and 2 h. Following treatment, lactate 
dehydrogenase (LDH) release and MTT reduction were measured as indices of 
cytotoxicity. Methylmercury and thimerosal caused significant time- and dose-dependent 
increases in LDH release in Caco-2 cells relative to untreated control cells (Figure 2A 
and B, respectively). Furthermore, methylmercury and thimerosal caused significant 
time- and dose-dependent decreases in MTT reduction in Caco-2 cells relative to 
untreated control cells (Figure 2C and D, respectively). These data revealed that mercury, 
as both methylmercury and thimerosal, caused significant time-and-dose dependent 
cytotoxicity in Caco-2 cells. 
 
Thiol-redox stabilizing drug, NBMI, attenuates mercury-induced cytotoxicity in 
colonic epithelial cells 
Previously, we have demonstrated that mercury-induced cytotoxicity in BPAECs 
was attenuated by the thiol-redox stabilizing drug, NBMI. Accordingly, we next 
examined the possibility that mercury-induced cytotoxicity in Caco-2 cells may occur 
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through thiol-redox destabilization and evaluated the effectiveness of NBMI in 
attenuating mercury-induced cytotoxicity in our colonic epithelial model. Caco-2 cells 
were pre-treated with NBMI (10, 25, and 50 µM) for 1 h prior to treatment with 
methylmercury (10 µM) and thimerosal (25 µM) for 1 h and LDH release and MTT 
reduction were measured following treatment as indices of cytotoxicity. In a significant 
dose-dependent fashion, NBMI attenuated mercury-induced increases in LDH release and 
MTT in Caco-2 cells (Figure 3). These results revealed that mercury-induced cytotoxicity 
in Caco-2 cells likely occurs through thiol-redox destabilization and NBMI is effective in 
attenuating mercury-induced cytotoxicity. 
 
NBMI attenuates mercury-induced cytotoxicity with greater efficacy than well-
established thiol-protectant antioxidants in colonic epithelial cells 
After observing that NBMI attenuated mercury-induced cytotoxicity in Caco-2 
cells, we next sought to compare the efficacy of NBMI to well-established thiol-redox 
stabilizing antioxidants in attenuating mercury-induced cytotoxicity. Specifically, we 
used the widely popular drugs N-acetlycysteine (NAC) and dimercaptosuccinic acid 
(DMSA) in our comparative analysis. Caco-2 cells were pre-treated with NBMI (50 µM), 
NAC (50 µM), and DMSA (50 µM) for 1 h prior to treatment with methylmercury (10 
µM) and thimerosal (25 µM) for 1 h. Following treatment, LDH release was measured as 
an index of cytotoxicity. NBMI-treated Caco-2 cells demonstrated significantly less LDH 
release when compared to cells treated with methylmercury and thimerosal alone (Figure 
4). Furthermore, the NBMI attenuation of mercury-induced LDH release was 
significantly greater than the attenuation exhibited by NAC and DMSA pre-treated Caco-
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2 cells. Consequently, this experiment revealed that NBMI attenuated mercury-induced 
cytotoxicity with significantly greater efficacy than the well-established thiol-protectant 
antioxidant drugs, NAC and DMSA. 
 
Mercury causes alterations in cell morphology of colon epithelial cells 
Earlier studies have shown that mercury-induced cytotoxicity is associated with 
alterations in cellular morphology. As further investigation of mercury-induced 
cytotoxicity, we studied whether cellular morphology of Caco-2 cells would be altered 
after treatment with mercury. To determine this possibility, Caco-2 cells were treated 
with methylmercury (1, 5, and 10 µM) and thimerosal (5, 10, and 25 µM) for 1 h. 
Following treatment, we digitally captured microscopic images of cellular morphology. 
Methylmercury and thimerosal caused significant dose-dependent alterations in the 
morphology of Caco-2 cells relative to untreated control cells (Figure 5A and B, 
respectively). These data revealed that mercury, as both methylmercury and thimerosal, 
caused substantial morphological alterations in Caco-2 cells indicative of cytotoxicity.  
 
NBMI protects against mercury-induced cell morphology alterations in colon 
epithelial cells  
After observing that NBMI attenuated mercury-induced cytotoxicity in Caco-2 
cells, we sought to investigate whether morphological alterations in Caco-2 cells would 
be attenuated by NBMI. To study this, Caco-2 cells were pre-treated with NBMI (50 µM) 
for 1 h prior to treatment with methylmercury (10 µM) and thimerosal (25 µM) for 1 h. 
Following treatment, we visually captured images of microscopic cellular morphology. 
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NBMI significantly attenuated mercury-induced morphological alterations in Caco-2 
cells (Figure 6). These results revealed that NBMI is effective in attenuating cytotoxic 
alterations in cellular morphology caused by methylmercury and thimerosal.  
 
Mercury inhibits proliferation of colon epithelial cells and NBMI protects against 
mercury-induced inhibition of proliferation of colon epithelial cells 
In this study, we have shown that NBMI protects against mercury-induced 
cytotoxicity in Caco-2 cells. These results led us to investigate whether NBMI would also 
ameliorate mercury-induced inhibition of cellular proliferation. To examine this 
possibility, we measured [3H]-thymidine incorporation after Caco-2 cells were pre-treated 
with NBMI (50 µM) for 1 h prior to treatment with methylmercury (10 µM) and 
thimerosal (25 µM) for 1 h. Significant decreases in [3H]-thymidine incorporation were 
observed in Caco-2 cells treated with mercury, relative to untreated control cells. 
Furthermore, NBMI significantly attenuated methylmercury- and thimerosal-induced 
decreases in [3H]-thymidine incorporation (Figure 7A and B, respectively). These data 
demonstrated that mercury inhibits cellular proliferation and NBMI ameliorates mercury-
induced inhibition of cellular proliferation. 
 
Mercury enhances ROS production in colon epithelial cells and NBMI attenuates 
mercury-induced ROS production in colon epithelial cells 
Earlier, we reported that mercury causes cytotoxicity in BPAECs through 
generation of ROS. This finding and our early demonstration that mercury causes 
cytotoxicity in Caco-2 cells led us to investigate whether mercury causes cytotoxicity in 
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Caco-2 cells through generation of intracellular ROS. To investigate this possible 
mechanism, we measured the formation of intracellular ROS using DCFDA following 
treatment with methylmercury (10 µM) and thimerosal (25 µM) for 30 min. Caco-2 cells 
treated with mercury exhibited significant increases in DCFDA fluorescence relative to 
untreated control cells. Furthermore, NBMI significantly attenuated mercury-induced 
increases in DCFDA fluorescence to near control levels (Figure 8). Collectively, this data 
suggests that mercury-induced cytotoxicity in Caco-2 cells occurs through significant, 
temporally upstream generation of ROS and NBMI is effective in attenuating mercury-
induced ROS generation.  
 
Mercury depletes GSH (thiol-redox) in colon epithelial cells and NBMI stabilizes 
depletion of GSH in colon epithelial cells 
Previous studies have shown that generation of intracellular ROS leads to a 
depletion of glutathione (GSH). This finding and our observation that mercury-induced 
cytotoxicity in Caco-2 cells occurs through significant generation of ROS led us to study 
whether depletion of GSH occurs concomitantly with mercury-induced cytotoxicity in 
Caco-2 cells. To investigate this possible mechanism, Caco-2 cells were pre-treated with 
NBMI (50 µM) for 1 h prior to treatment with methylmercury (10 µM) and thimerosal 
(25 µM) for 2 h. Following treatment, intracellular level of GSH were measured 
spectrophotometrically. Caco-2 cells treated with mercury exhibited significant decreases 
in GSH levels relative to untreated controls. In addition, NBMI stabilized mercury-
induced depletion of GSH to near control levels (Figure 9). This data suggested that 
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mercury-induced generation of ROS led to GSH depletion and NBMI stabilized mercury-
induced GSH diminution in Caco-2 cells. 
 
Mercury causes loss of TEPCR (barrier dysfunction) in a dose- and time-dependent 
fashion 
Oxidants were shown in earlier studies to induce changes in cell-to-cell adhesions 
that result in a drop in electrical resistance across epithelial and endothelial monolayers 
(Sliman et al., 2009 and Elton et al., 200X). To further investigate our hypothesis that 
mercury contributes to leaky gut syndrome through disrupting cell-to-cell adhesion 
within the colonic epithelium, Caco-2 cells were treated with methylmercury (1, 5, and 
10 µM) and thimerosal (5, 10, and 25 µM) and changes in electrical resistance across 
confluent monolayers were measured in real time for 6 h via ECIS. Methylmercury (5 
and 10 µM) produced significant time- and dose-dependent decreases in electrical 
resistance in comparison to untreated control cells (Figure 10A & B). Thimerosal (5, 10, 
and 25 µM) also exhibited significant time-and dose-dependent diminution of electrical 
resistance relative to untreated control cells (Figure 10C & D). These data showed, for 
the first time, that mercury caused significant time- and dose-dependent losses in cell-to-
cell adhesion in Caco-2 cells. 
 
NBMI attenuates mercury-induced barrier dysfunction 
NBMI, which previously in this study demonstrated attenuation of mercury-
induced cytotoxicity, generation of ROS, and depletion of intracellular thiols, was next 
evaluated for efficacy in preventing mercury-induced barrier dysfunction. Caco-2 cells 
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were treated with NBMI (50 µM) alone, thimerosal  (25 µM) alone, or co-treated with 
NBMI (50 µM) and thimerosal (25 µM) together and electrical resistance was measured 
in real time for 6 h using ECIS. NBMI effectively attenuated thimerosal-induced 
decreases in electrical resistance across confluent monolayers to levels near untreated 
control cells (Figure 11). Consequently, this data demonstrated NBMI was effective in 
ameliorating mercury-induced barrier dysfunction in Caco-2 cells. 
 
Mercury enhances paracellular transport of macromolecules (FITC-Dextran) across 
colon epithelial cell layers and NBMI attenuates paracellular leak in colon epithelial 
cell layers 
Previously, we observed that mercury induces barrier dysfunction resulting in 
transcellular leak across the intestinal epithelium. We therefore sought to investigate 
whether mercury induces paracellular leak in Caco-2 cells. To determine paracellular 
transport of macromolecules across layers of Caco-2 cells, we used the FITC-Dextran 
permeability assay in which florescence is an indication of the leak that occurs across a 
membrane. Caco-2 cells were co-treated with NBMI (50 µM) and methylmercury (10 
µM) or thimerosal (25 µM) for 2 h. Following treatment fluorescence was measured as 
an indication of leak. Caco-2 cells treated with mercury had significant increases in 
fluorescence relative to untreated controls. In addition, NBMI significantly attenuated 
mercury-induced increase in fluorescence (Figure 12). These results reveal that mercury 
enhances paracellular transport of macromolecules across Caco-2 cell layers and NBMI 
is effective in attenuating mercury-induced paracellular leak.  
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Mercury causes actin stress fiber formation which is attenuable through NBMI 
treatment 
         Cytoskeletal rearrangements in colonic epithelial cells, including the formation of 
actin stress fibers, have been repeatedly established with leaky gut syndrome. However, 
the formation of actin stress fibers in response to mercury in Caco-2 cells has never been 
investigated. Here, we hypothesized that mercury would cause formation of actin stress 
fibers resultant from ROS generation, which was previously demonstrated. To test our 
hypothesis, Caco-2 cells were treated with NBMI (50 µM) alone, mercury 
(methylmercury [10 µM] and thimerosal [25 µM]) alone, or co-treated with NBMI (50 
µM) and mercury together for 30 min. Following treatment, cells were stained with actin-
specific monoclonal antibodies and visualized with fluorescent confocal microscopic 
immunohistochemistry. Mercury caused significant dose-dependent increases in actin 
stress fiber formation which were attenuated by NBMI (Figure 13). This experiment 
substantiated the notion that mercury could potentially contribute to leaky gut syndrome 
through inducing cytoskeletal rearrangements in colonic epithelial cells. 
 
NBMI attenuates mercury-induced alterations in intercellular adhesions 
Having shown mercury causes paracellular leak and cytoskeletal rearrangements 
in Caco-2 cells, we next investigated whether mercury would affect cell-to-cell adhesion 
proteins. We evaluated this potential effect through the use of fluorescent confocal 
microscopic immunohistochemistry with ZO-1- and occludin-specific antibodies. Caco-2 
cells were treated with NBMI (50 µM) alone, mercury (methylmercury [10 µM] and 
thimerosal [25 µM]) alone, or co-treated with NBMI (50 µM) and mercury together for 
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30 min and then stained, fixed, mounted, and images were captured digitally. Both 
thimerosal and methylmercury caused significant alterations in ZO-1 and occludin 
intracellular staining which were attenuated by NBMI (Figure 14). This data further 
substantiated the notion that mercury contributes to leaky gut syndrome through 
disrupting the integral membrane proteins which form tight junctions in the colonic 
epithelium. 
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DISCUSSION 
The results of the current study revealed that the two forms of mercury, 
methylmercury (organic form) and thimerosal (pharmaceutical form) caused cytotoxicity, 
depletion of intracellular GSH, enhanced formation of ROS, decreased cell proliferation, 
barrier dysfunction, increased paracellular transport of macromolecules, actin 
cytoskeletal reorganization, and tight-junction alterations in the Caco-2 colon epithelial 
cells. Furthermore, the results of the current study also demonstrated that the novel thiol-
redox-stabilizing antioxidant and heavy metal chelating drug, NBMI effectively 
attenuated the mercury-induced cytotoxicity, tight junction alterations, and increase in 
paracellular leak in Caco-2 cells. This is the first evidence which demonstrated that 
mercury induced intestinal epithelial cell damage, cytoskeletal and tight junction 
alterations, and macromolecule leak through thiol-redox depletion and oxidative stress 
which was effectively protected by the novel thiol-redox stabilizer, NBMI.  
 
Mercury is a serious environmental pollutant, occupational hazard, and 
pharmaceutical toxicant (Hagele et al.). Mercury-containing dental amalgams have been 
identified to contribute mercury toxicity in humans (McCullough and Tyas 2008). 
Mercury, both inorganic and organic forms, has been established as potent toxic heavy 
metal with cytotoxic, neurotoxic, and teratogenic effects. Mercury-induced neuronal cell 
death and neurotoxicity have been reported (Choi et al. 2011). Mercury has also been 
shown to cause mitochondria-dependent apoptosis in hepatocytes (Pal et al. 2012). 
Inorganic mercury has been observed to cause pancreatic beta-cell death through 
oxidative stress-mediated apoptosis and necrosis (Chen et al. 2010). Trolox, a water-
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soluble form of vitamin E, has been demonstrated to prevent methylmercury-induced 
ROS generation and neurotoxicity in glial cells (Kaur et al. 2010). In neurons, 
methylmercry has been shown to cause cytotoxicity through oxidative stress (Zhang et al. 
2009). Cytotoxicity of thimerosal has been reported to be mediated by thiol-modulated 
mechanism (Wu et al. 2008). Role of ROS and thiol-redox depletion have been shown to 
mediate mercury-induced phospholipase A2 and D activation in vascular endothelial cells 
(Hagele; Mazerik). The involvement of glutamate and ROS in methylmercury 
neurotoxicity has been emphasized (Aschner et al. 2007). It has also been shown that N-
acetyl-L-cysteine (NAC) and the novel thiol-redox antioxidant and heavy metal chelating 
agent, NBMI protects against mercury- and oxidant-induced activation of phospholipase 
D, GSH depletion, ROS generation, and oxidative stress in vascular endothelial cells 
(Secor et al. 2011; Patel et al. 2012). These reports offer substantial support in favor of 
the findings of the current study that mercury (both methylmercury and thimerosal) 
caused ROS- and thiol-redox-mediated cytotoxicity in the Caco-2 colon epithelial cells 
that was protected by the thiol-redox stabilization by the classic thiol protectant, NAC 
and the novel lipophilic thiol-redox antioxidant and heavy metal chelator, NBMI. 
 
Studies with in vivo mouse model have revealed the endothelial barrier dysfunction 
and enhanced paracellular permeability in lung following bleomycin exposure (Yin et al. 
2012). Tight junction proteins have been shown to be crucial for cellular contacts 
including the epithelial and endothelial cells of the ECs (Utech et al. 2006; Van Itallie 
and Anderson, 2006). Zonula occludens-1 (ZO-1) and occludins are important tight 
junction proteins. The actin-cytoskeleton is important machinery for the maintenance of 
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the cellular architecture for proper physiological functions and the intestinal epithelial 
cells including the Caco-2 cells are no exception to this. The actin microfilaments have 
been recognized as the critical players in the regulation of endothelial barrier and similar 
regulation of the intestinal barrier by the epithelial cytoskeleton is expected (Dudek and 
Garcia, 2001). The ZO-1 and actin-cytoskeleton are tightly associated and if this 
association is altered, the barrier function and paracellular permeability are dysregulated 
as seen in the endothelial cell monolayers (Kawkitinarong et al. 2004). Oxidants and 
oxidative stress alter the architecture and function of the cytoskeletal and tight junction 
protein machinery and association through thiol-redox dysregulation, wherein the 
intracellular GSH dysregulation plays a major role. ROS and the lipid peroxidation-
generated reactive carbonyl, 4-hydroxy-2-nonenal (4-HNE) have been recognized as 
potent disruptors of the cytoskeletal-tight junction assembly leading to the endothelial 
barrier dysfunction in the lung microvessels (Usatyuk et al. 2006; Uchida 2003). The 
hyperglycemic oxoaldehyde and the advanced glycation endproduct precursor, glyoxal, 
has been shown to cause endothelial barrier dysfunction that is associated with the actin 
cytoskeletal rearrangement and tight junction protein alterations (Sliman et al. 2010). 
Oxidants including hydrogen peroxide and diamide have been demonstrated to cause the 
disruption of the tight junction proteins such as ZO-1 and occludins leading to the altered 
epithelial barrier function (Chapman et al. 2002; Usatyuk et al. 2003).  Mercury has been 
shown to cause neurocytotoxicity and cytoskeletal reorganization in chick embryo 
neurons (Choi et al. 2011). Thiol-protectants including NAC have been shown to protect 
against the oxidant-induced endothelial barrier disruption (Usatyuk et al. 2003). In Caco-
2 cells, it has been shown that mercury causes tight junction alterations with altered beta-
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actin synthesis and paracellular permeability (Calabro et al. 2011). This study signifies 
that mercury disrupts intestinal barrier function through tight junction alterations. In 
addition, another study reveals that methylmercury causes cytotoxicity in Caco-2 cells as 
demonstrated by the capillary zone electrophoresis (Zhang et al. 2012). Therefore, the 
results of the current study concurred with these findings demonstrating that the mercury-
induced cytoskeletal reorganization, tight junction protein alterations, and barrier 
dysfunction in the Caco-2 colon epithelial cells were caused by mercury through 
oxidative stress and thiol-redox alterations. In addition, this study clearly revealed that 
the novel thiol-redox antioxidant and heavy metal chelator, NBMI was an effective agent 
in protecting against the mercury-induced actin cytoskeletal rearrangement, tight junction 
protein alterations, and enhanced paracellular permeability of macromolecules in the 
Caco-2 colon epithelial cells in culture, apparently through the stabilization of 
intracellular thiol-redox, scavenging/quenching of ROS, and chelating the toxic mercury 
species.  
 
On the whole, the results of the current study clearly demonstrated that both forms of 
mercury (methylmercury and thimerosal) caused cytotoxicity, generation of ROS, loss of 
thiols, increase in paracellular permeability, cytoskeletal reorganization, tight junction 
protein alterations, and barrier dysfunction in the Caco-2 colon epithelial cells and these 
adverse cellular effects were all protected by the thiol-protectants suggesting the role of 
thiol-redox dysregulation in the mercury-induced epithelial cytotoxicity and barrier 
dysfunction (Schema-1). Besides, this study was the first observation to demonstrate that 
the novel lipid-soluble thiol-protectant, NBMI, was more effective as compared to the 
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commonly used water-soluble thiol-protectant (antioxidant), NAC, in offering protection 
against the mercury-induced cytotoxicity, oxidative stress, thiol-redox dysregulation, 
cytoskeletal rearrangement, tight junction protein alterations, and barrier dysfunction in 
the colon epithelial cells. Above all, the current study also demonstrated that NBMI 
offered effective protection against the mercury-induced toxicity at μM dose, whereas 
mM concentration of NAC was required to achieve such protection in the Caco-2 colon 
epithelial cells. Structurally, NBMI resembles the dicarboxybenzoate moiety bound to 
two cysteamines as found naturally in fruits. Therefore, NBMI is expected to act as both 
heavy metal chelator and free radical scavenger. The ability of NBMI to complex with 
trace heavy metals has been reported (Zaman et al. 2007). Thus, mercury could have been 
also chelated by NBMI in addition to the ability of NBMI acting as an antioxidant and 
thiol-protecting agent against the mercury-induced oxidative stress as observed in the 
current study in the Caco-2 colon epithelial cells. Furthermore, the lipophilic nature of 
NBMI could have offered advantage to the molecule to selectively partition in the lipid-
rich hydrophobic microenvironments of the cellular membranes where the redox-
regulated cellular reactions take place and thus protecting against the mercury-induced 
toxicity in the colon epithelial cells. The novel bifunctional chelating drug, such as 
NBMI, with thiol-redox stabilizing and antioxidant actions and heavy metal chelating 
ability appears as a promising therapeutic agent against the mercury- and oxidant-induced 
intestinal epithelial damage. 
 
The rationale for the current work hinges on the leaky intestine, leaky-gut syndrome, 
and pediatric intestinal diseases (Liu et al. 2005). Tight junctions have been identified as 
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crucial players in regulating the barrier for paracellular transport in the intestine and 
disruption of the tight junctions has been connected with the conditions of intestinal 
hyperpermeability such as the leaky-gut syndrome (Liu et al. 2005). Oxidative and 
nitrosative stress have been recognized as important players in leaky-gut syndrome and 
the associated cardiovascular disorders (Maes and Twisk, 2009). Mercury has been 
implicated in cardiovascular diseases, autism, and neurological disorders (Hagele et al.). 
Therefore, the role of mercury in the etiology of leaky-gut syndrome may be emphasized. 
Along these lines, the protective role of thiol-redox stabilizers, especially the novel thiol-
redox antioxidant and heavy metal chelator, NBMI against mercury-induced cytotoxicity 
and paracellular hyperpermeability in the intestinal epithelium appears to offer 
pharmacological intervention of leaky-gut syndrome, wherein ROS, thiol-redox 
dysregulation, and oxidative stress play a critical mechanistic role. 
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FIGURE LEGENDS 
Figure 1. Chemical structures of mercuric compounds and antioxidants. (A) 
methylmercury chloride (MeHgCl2) (B) Thimerosal (C) N-acetylcysteine (NAC) (D) 
dimercaptosuccinic acid (DMSA) (E) N-bis-mercaptoethylisopthalamide (NBMI) 
Figure 2.  Mercury induces cytotoxicity in colon epithelial cells. Caco-2 cells (2.5x105 
cells/17.5-mm dish) were treated with MEM alone or MEM containing different 
concentrations (1, 5, 10 µM) of methylmercury or different concentrations (5, 10, 25 µM) 
of thimerosal for 1 and 2 hours. At the end of the incubation period, release of LDH into 
the medium (A&B) and decrease in MTT reduction (B&C) were determined 
spectrophotometrically. Data represent mean ± S.D. calculated from the independent 
experiments. *Significantly different at P<0.05 as compared to cells treated with MEM 
alone.  
Figure 3.  NBMI attenuates mercury-induced cytotoxicity in colon epithelial cells. Caco-
2 cells (2.5x105 cells/17.5-mm dish) were pretreated with MEM alone or MEM 
containing different concentrations (10, 25, 50 µM) of NBMI for 1 hour. Pre-treated cells 
were then treated with MEM alone, MEM containing methylmercury (10 µM) or 
thimerosal (25 µM), or MEM containing methylmercury (10 µM) and NBMI (50 µM) or 
thimerosal (25 µM) and NBMI (50 µM) for 1 hour. At the end of the incubation period, 
release of LDH into the medium (A&B) and decrease in MTT reduction (B&C) were 
determined spectrophotometrically. Data represent mean ± S.D. calculated from the 
independent experiments. *Significantly different at P<0.05 as compared to cells treated 
with MEM alone. **Significantly different at P<0.05 as compared to cells treated with 
MEM containing methylmercury or thimerosal alone. 
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Figure 4. Comparison of NAC and DMSA with NBMI in attenuating mercury-induced 
cytotoxicity in colon epithelial cells. Caco-2 cells (2.5x105 cells/17.5-mm dish) were 
pretreated with MEM alone, MEM containing NBMI (50 µM), MEM containing NAC 
(50 µM) or MEM containing DMSA (50 µM) for 1 hour. Pre-treated cells were then 
treated with MEM alone, MEM containing methylmercury (10 µM; A) or thimerosal 
(25µM; B), or MEM containing methylmercury (10 µM) and NBMI (50 µM), NAC (50 
µM), or DMSA (50 µM) or thimerosal (25 µM) and NBMI (50 µM), NAC (50 µM), or 
DMSA (50 µM) for 2 hours. At the end of the incubation period, release of LDH into the 
medium was determined spectrophotometrically. Data represent mean ± S.D. calculated 
from the independent experiments. *Significantly different at P<0.05 as compared to 
cells treated with MEM alone. **Significantly different at P<0.05 as compared to cells 
treated with MEM containing methylmercury or thimerosal alone.  
Figure 5. Mercury causes alterations in cell morphology of colon epithelial cells. Caco-2 
cells (5x105cells/25-mm dish) were treated with MEM alone, MEM containing different 
concentrations (1, 5, 10 µM) of methylmercury (A), or MEM containing different 
concentrations (5, 10, 25 µM) of thimerosal (B) for 1 hour. At the end of the incubation 
period, the cell morphology was examined under light microscope (as an index of 
cytotoxicity). Each micrograph is a representative picture obtained from 3 independent 
experiments conducted under identical conditions. 
Figure 6. NBMI protects against mercury-induced cell morphology alterations in colon 
epithelial cells. Caco-2 cells (5x105cells/35-mm dish) were treated with MEM alone, 
MEM containing methylmercury (10 µM) or thimerosal (25 µM), or MEM containing 
methylmercury (10 µM) and NBMI (50 µM) or thimerosal (25 µM) and NBMI (50 µM) 
 43
for 1 hour. At the end of the incubation period, the cell morphology was examined under 
light microscope (as an index of cytotoxicity). Each micrograph is a representative 
picture obtained from 3 independent experiments conducted under identical conditions.  
Figure 7. Mercury inhibits proliferation of colon epithelial cells and NBMI protection. 
Caco-2 cells (5x105cells/35-mm dish) were pretreated with MEM alone or MEM 
containing NBMI (50 µM) for 1 hour. Pre-treated cells were then treated with MEM 
alone, MEM containing methylmercury (10 µM) or thimerosal (25 µM), or MEM 
containing methylmercury (10 µM) and NBMI (50 µM) or thimerosal (25 µM) and 
NBMI (50 µM) for 1 hour. At the end of incubation, cells were labeled with [3H]-
thymidine (1 mCi/ml) in complete EC medium for 24 h. Cell replication at the end of the 
treatment was assayed by determining [3H]-thymidine incorporated into the cells as 
described in materials and methods.  Data represent means + SD of independent 
experiment. * Significantly different at P < 0.05 as compared with the cells treated with 
MEM alone. **Significantly different at P<0.05 as compared to cells treated with MEM 
containing methylmercury or thimerosal alone.  
Figure 8. Mercury enhances ROS production in colon epithelial cells and NBMI 
attenuation. Caco-2 cells (5x105cells/35-mm dish) were preloaded with 10 mmol/L 
DCFDA for 30 minutes in complete MEM to determine ROS generation. Following the 
DCDA loading, cells were subjected to treatment with MEM alone, MEM containing 
methylmercury (10 µM) or thimerosal (25 µM), or MEM containing methylmercury (10 
µM) and NBMI (50 µM) or thimerosal (25 µM) and NBMI (50 µM) for 30 minutes. At 
the end of the incubation period, the DCFDA fluorescence (as an index of ROS 
formation) was determined as described under Materials and Methods section. Each 
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micrograph is a representative picture obtained from 3 independent experiments 
conducted under identical conditions. *Significantly different at P<0.05 as compared to 
cells treated with MEM alone. **Significantly different at P<0.05 as compared to cells 
treated with MEM containing methylmercury or thimerosal alone. DCFDA indicates 2’-
7’-dichlorofluorescin diacetate; MEM, minimal essential medium; ROS, reactive oxygen 
species.  
Figure 9. Mercury depletes GSH (thiol-redox) in colon epithelial cells and stabilization 
by NBMI. Caco-2 cells (5x105cells/96 well plates) were pretreated with MEM alone or 
MEM containing NBMI (50 µM) for 1 hour. Pre-treated cells were then treated with 
MEM alone, MEM containing methylmercury (10 µM) or thimerosal (25 µM), or MEM 
containing methylmercury (10 µM) and NBMI (50 µM) or thimerosal (25 µM) and 
NBMI (50 µM) for 2 hours to determine intracellular GSH levels. At the end of the 
incubation period, the intracellular soluble thiol (GSH) concentrations were determined. 
Data represent mean + SD calculated from 3 independent experiments. *Significantly 
different at P<0.05 as compared to cells treated with MEM alone. **Significantly 
different at P<0.05 as compared to cells treated with MEM containing methylmercury or 
thimerosal alone. GSH indicates glutathione. 
Figure 10. Mercury causes loss of TEPCR (barrier dysfunction) in a dose- and time-
dependent fashion. Caco-2 cell layers were cultured in complete MEM on gold electrodes 
and exposed to MEM alone or MEM containing different concentrations (1, 5, 10 µM; 
A&B) of methylmercury or different concentrations (5, 10, 25 µM; C&D) of thimerosal 
for 20 h in a humidified atmosphere of 5%CO2-95% air at 37oC and the TEPCR was 
measured continuously in an ECIS system as described in materials and methods. A and 
 45
C are representative tracings of the normalized resistance values of two independent 
experiments conducted under identical conditions. B and D is the graphical representation 
of the averaged normalized resistance values obtained from two independent 
determinations at specified time points. Data represent means + SD of independent 
experiment.  
Figure 11. NBMI attenuates mercury-induced loss of TEPCR (barrier dysfunction). 
Caco-2 cell layers were cultured in complete MEM on gold electrodes and exposed to 
MEM alone, MEM containing methylmercury (10 µM, A&C) or thimerosal (25 µM, 
B&D), or MEM containing methylmercury (10 µM) and NBMI (50 µM) or thimerosal 
(25 µM) and NBMI (50 µM) for 20 h in a humidified atmosphere of 5%CO2-95% air at 
37oC and the TEPCR was measured continuously in an ECIS system as described in 
materials and methods. A and C are representative tracings of the normalized resistance 
values of two independent experiments conducted under identical conditions. B and D is 
the graphical representation of the averaged normalized resistance values obtained from 
two independent determinations at specified time points. Data represent means + SD of 
independent experiment.  
Figure 12. Mercury enhances paracellular transport of macromolecules (FITC-Dextran) 
across colon epithelial cell layers and NBMI attenuation. Caco-2 cells (2.5x105 
cells/17.5-mm dish) were treated with MEM alone, MEM containing methylmercury (10 
µM) or thimerosal (25 µM), or MEM containing methylmercury (10 µM) and NBMI (50 
µM) or thimerosal (25 µM) and NBMI (50 µM) for 2 hours. At the end of incubation, 
FITC fluorescence (as an index of EC leak) was determined spectrophotometrically as 
described in materials and methods. Data represent means + SD of independent 
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experiment. * Significantly different at P < 0.05 as compared with the cells treated with 
MEM alone. **Significantly different at P<0.05 as compared to cells treated with MEM 
containing methylmercury or thimerosal alone. 
Figure 13. Mercury causes actin cytoskeleton rearrangements in colon epithelial cells 
and NBMI protection. Caco-2 cells (5x105cells/35-mm dish) were treated with MEM 
alone, MEM containing methylmercury (10 µM) or thimerosal (25 µM), or MEM 
containing methylmercury (10 µM) and NBMI (50 µM) or thimerosal (25 µM) and 
NBMI (50 µM) for 30 minutes. At the end of incubation, cells were fixed and stained for 
Actin Stress Fibers. Each image is a representative picture obtained from the independent 
experiment conducted under identical conditions. 
Figure 14. Mercury induced tight junction alterations (ZO-1 and Occludins) in colon 
epithelial cells and NBMI protection. Caco-2 cells (5x105cells/35-mm dish) were treated 
with MEM alone, MEM containing methylmercury (10 µM) or thimerosal (25 µM), or 
MEM containing methylmercury (10 µM) and NBMI (50 µM) or thimerosal (25 µM) and 
NBMI (50 µM) for 30 minutes. At the end of incubation, cells were fixed and stained for 
Tight Junction Protein (ZO1) and Tight Junction Protein (Occludin) as described in 
materials and methods. Each image is a representative picture obtained from the 
independent experiment conducted under identical conditions. 
Schema 1: Proposed mechanism of mercury-induced cytotoxicity in Caco-2 colon 
epithelial cells through ROS generation, thiol-redox dysregulation, inhibition of cell 
proliferation, mitochondrial dysfunction, tight junction alterations, cytoskeletal 
reorganization, and paracellular hyperpermeability. 
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